Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CLK1 | P49759 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | ERN1 | O75460 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20281311 | 0.81 | GPR84 (0.44) | ALDH1A1HIF1ACYP1B1HSD17B10CA1 | |
| SCHEMBL8009194 | 0.77 | CA2 (0.50) | ALDH1A1HIF1ACYP1B1HSD17B10CA2 | |
| SCHEMBL1325698 | 0.75 | GPR84 (0.36) | ALDH1A1HIF1ACYP1B1HSD17B10CA1 | |
| SCHEMBL29518510 | 0.71 | ALDH1A1 (0.50) | ALDH1A1HIF1ACYP1B1HSD17B10POLB | |
| SCHEMBL5637840 | 0.71 | ALDH1A1 (0.50) | ALDH1A1HIF1ACYP1B1HSD17B10POLB | |
| SCHEMBL7106896 | 0.70 | KDM4E (0.42) | ALDH1A1POLB | |
| Cyanate SCHEMBL7106900 | 0.70 | POLB (0.40) | ALDH1A1HIF1ACYP1B1HSD17B10CA1 | |
| SCHEMBL1325259 | 0.69 | MAPT (0.41) | ALDH1A1HIF1ACYP1B1HSD17B10CA1 | |
| SCHEMBL27844346 | 0.68 | HSD17B10 (0.39) | ALDH1A1HIF1ACYP1B1HSD17B10CA1 | |
| SCHEMBL7108615 | 0.68 | CYP2A6 (0.48) | ALDH1A1HIF1ACYP1B1HSD17B10CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6458993-B1 | AROMATIC CYANATE ESTER COMPOUNDS HAVING AT LEAST TWO RINGS LINKED BY AN UNSATURATED GROUP CONTAINING MEMBER CAN BE EMPLOYED IN ADHESIVES, COMPOSITES, LAMINATES AND MOLDINGS | VANTICO INC. | 2002-10-01 | — | — | US | claimed |
| US-20020055648-A1 | Cyanate esters having flame resistant properties | JPMORGAN CHASE BANK, N.A. | 2002-05-09 | — | — | US | claimed |
| EP-1161414-B1 | CYANATE ESTERS HAVING FLAME RESISTANT PROPERTIES | VANTICO AG (CH) | 2003-10-01 | — | — | EP | disclosed |
| US-6458993-B1 | AROMATIC CYANATE ESTER COMPOUNDS HAVING AT LEAST TWO RINGS LINKED BY AN UNSATURATED GROUP CONTAINING MEMBER CAN BE EMPLOYED IN ADHESIVES, COMPOSITES, LAMINATES AND MOLDINGS | VANTICO INC. | 2002-10-01 | — | — | US | disclosed |
| US-20020055648-A1 | Cyanate esters having flame resistant properties | JPMORGAN CHASE BANK, N.A. | 2002-05-09 | — | — | US | disclosed |
| EP-1161414-A1 | CYANATE ESTERS HAVING FLAME RESISTANT PROPERTIES | Vantico AG (CH) | 2001-12-12 | — | — | EP | disclosed |
| US-6242638-B1 | FIREPROOFING USING CURED MIXTURES | VANTICO INC. | 2001-06-05 | — | — | US | disclosed |
| WO-2000055123-A1 | CYANATE ESTERS HAVING FLAME RESISTANT PROPERTIES | VANTICO AG (CH) | 2000-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020055648-A1 | Cyanate esters having flame resistant properties | PCCA, FABP4, MCCC2 | ALDH1A1 1536/4885HIF1A 3186/4885CYP1B1 1223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.